Literature DB >> 11777830

Identification of Acinetobacter isolates from species belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with monoclonal antibodies specific for O Antigens of their lipopolysaccharides.

Ralph Pantophlet1, Juliëtte A Severin, Alexandr Nemec, Lore Brade, Lenie Dijkshoorn, Helmut Brade.   

Abstract

The unambiguous identification of Acinetobacter strains, particularly those belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex, is often hindered by their close geno- and phenotypic relationships. In this study, monoclonal antibodies (MAbs) against the O antigens of the lipopolysaccharides from strains belonging to the A. calcoaceticus-A. baumannii complex were generated after the immunization of mice with heat-killed bacteria and shown by enzyme immunoassays and Western blotting to be specific for their homologous antigens. Since the A. calcoaceticus-A. baumannii complex comprises the most clinically relevant species, the MAbs were subsequently tested in dot and Western blots with proteinase K-treated lysates from a large collection of Acinetobacter isolates (n = 631) to determine whether the antibodies could be used for the reliable identification of strains from this complex. Reactivity was observed with 273 of the 504 isolates (54%) from the A. calcoaceticus-A. baumannii complex which were included in this study. Isolates which reacted positively did so with only one antibody; no reactivity was observed with isolates not belonging to the A. calcoaceticus-A. baumannii complex (n = 127). To identify additional putative O serotypes, isolates from the A. calcoaceticus-A. baumannii complex which showed no MAb reactivity were subjected to a method that enables the detection of lipid A moieties in lipopolysaccharides with a specific MAb on Western blots following acidic treatment of the membrane. By this method, additional serotypes were indeed identified, thus indicating which strains to select for future immunizations. This study contributes to the completion of a serotype-based identification scheme for Acinetobacter species, in particular, those which are presently of the most clinical importance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11777830      PMCID: PMC119878          DOI: 10.1128/cdli.9.1.60-65.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  29 in total

1.  Generation and serological characterization of murine monoclonal antibodies against O antigens from Acinetobacter reference strains.

Authors:  R Pantophlet; L Brade; H Brade
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

2.  Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A.

Authors:  H M Kuhn; L Brade; B J Appelmelk; S Kusumoto; E T Rietschel; H Brade
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

3.  Delineation of new proteolytic genomic species in the genus Acinetobacter.

Authors:  P J Bouvet; S Jeanjean
Journal:  Res Microbiol       Date:  1989 May-Jun       Impact factor: 3.992

4.  Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens.

Authors:  A Nemec; T De Baere; I Tjernberg; M Vaneechoutte; T J van der Reijden; L Dijkshoorn
Journal:  Int J Syst Evol Microbiol       Date:  2001-09       Impact factor: 2.747

5.  Genotypic and phenotypic similarity of multiresistant Acinetobacter baumannii isolates in the Czech Republic.

Authors:  A Nemec; L Janda; O Melter; Lenie Dijkshoorn
Journal:  J Med Microbiol       Date:  1999-03       Impact factor: 2.472

6.  Reliability of phenotypic tests for identification of Acinetobacter species.

Authors:  P Gerner-Smidt; I Tjernberg; J Ursing
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

7.  Clinical strains of Acinetobacter classified by DNA-DNA hybridization.

Authors:  I Tjernberg; J Ursing
Journal:  APMIS       Date:  1989-07       Impact factor: 3.205

8.  Ribotyping of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex.

Authors:  P Gerner-Smidt
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

9.  [Clinical importance of Acinetobacter calcoaceticus isolations from blood and venous catheters].

Authors:  M Hoppe; J Potel; R Malottke
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1983-11

10.  Infections with Acinetobacter calcoaceticus (Herellea vaginicola): clinical and laboratory studies.

Authors:  R H Glew; R C Moellering; L J Kunz
Journal:  Medicine (Baltimore)       Date:  1977-03       Impact factor: 1.889

View more
  3 in total

1.  Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii.

Authors:  Hongjiang Yang; Li Liang; Shuxiang Lin; Shiru Jia
Journal:  BMC Microbiol       Date:  2010-04-29       Impact factor: 3.605

2.  Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii.

Authors:  Mark D Adams; Karrie Goglin; Neil Molyneaux; Kristine M Hujer; Heather Lavender; Jennifer J Jamison; Ian J MacDonald; Kristienna M Martin; Thomas Russo; Anthony A Campagnari; Andrea M Hujer; Robert A Bonomo; Steven R Gill
Journal:  J Bacteriol       Date:  2008-10-17       Impact factor: 3.490

3.  Diversity in the major polysaccharide antigen of Acinetobacter baumannii assessed by DNA sequencing, and development of a molecular serotyping scheme.

Authors:  Dalong Hu; Bin Liu; Lenie Dijkshoorn; Lei Wang; Peter R Reeves
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.